Showing results (41-50 of 168) with videos related to

Sort By:
Pageof 17
Tuberculosis (Edinburgh, Scotland)|December 3, 2014
Future target-based drug discovery for tuberculosis?Bavesh Davandra Kana, Petros C Karakousis, Tanya Parish, et al.
FEMS Microbiology Letters|August 6, 2008
Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 of Mycobacterium tuberculosisMartin Gengenbacher, Ting Xu, Pornwaratt Niyomrattanakit, et al.
Microbiology Spectrum|July 17, 2023
Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessusDereje A Negatu, Wassihun Wedajo Aragaw, Véronique Dartois, et al.
Frontiers in Microbiology|March 21, 2020
Extreme Drug Tolerance of Mycobacterium abscessus "Persisters"Yee-Kuen Yam, Nadine Alvarez, Mei-Lin Go, et al.
Antimicrobial Agents and Chemotherapy|September 22, 2020
Resistance against Membrane-Inserting MmpL3 Inhibitor through Upregulation of MmpL5 in Mycobacterium tuberculosisMing Li, Samuel Agyei Nyantakyi, Mei-Lin Go, et al.
Future Microbiology|May 10, 2016
Membrane-targeting AM-0016 kills mycobacterial persisters and shows low propensity for resistance developmentDevika Mukherjee, Hanxun Zou, Shouping Liu, et al.
Biochemical and Biophysical Research Communications|November 26, 2019
Overexpression, purification, enzymatic and microscopic characterization of recombinant mycobacterial F-ATP synthaseWuan-Geok Saw, Chui-Fann Wong, Thomas Dick, et al.
Microbiology (Reading, England)|October 3, 2009
Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viabilityMartin Gengenbacher, Srinivasa P S Rao, Kevin Pethe, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2022
Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung DiseaseDereje A Negatu, Matthew D Zimmerman, Véronique Dartois, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2024
A pairwise approach to revitalize β-lactams for the treatment of TBDereje A Negatu, Wassihun Wedajo Aragaw, Véronique Dartois, et al.
Pageof 17